Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Meyer 1989
As a synthetic analog, DSIP exhibits poor oral bioavailability and is typically administered via parenteral routes for research purposes
Unlike many peptide-based compounds that require specialized delivery systems (such as injectable carriers) or are rapidly broken down by digestive enzymes, BPC-157's inherent resistance to hydrolysis and enzymatic digestion allows for its potential oral administration
Increased transcription of the regulatory subunit of -glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion
US$ 22.57
US$ 26.36
US$ 22.11
US$ 26.78
